Aurobindo gets USFDA nod for antibiotic

Aurobindo Pharma has secured the final approval from the USFDA to make Azithromycin tablets 250 mg and 500 mg. The company said the product would be introduced this month. The product has an estimated market size of $132 million for the 12 months ended May 2018, Aurobindo said. The tablets are an AB-rated generic equivalent of Pfizer’s Zithromax tablets and are indicated for treatment of mild to moderate infections.

Source: Read Full Article